MHRA updates guidance on licensing of biosimilars

AdobeStock_94355258

Updated guidance on the licensing of biosimiar products, based on the current European Medicines Agency biosimilar guidance, has been published by the MHRA

Please register to continue reading this content

Guidelines is completely free for all UK-based healthcare professionals